MRFRの分析によると、世界のセルライト処理市場は予測期間中、8.97％の注目すべきCAGRを遂げ、2027年末までに最大の市場価値10億8,644万ドルを記録すると予測されます。 セルライトは、太もも、後端の股関節、および中央部に不均一なくぼみのある組織を引き起こす皮膚のくぼみです。セルライトの存在に対処するためのさまざまな治療法があります。世界市場の拡大を促す要因は、スタイリッシュな矯正技術への関心の高まりと、世界的な肥満の蔓延です。
世界のセルライト治療市場は、世界的な症例の増加、品の良い矯正システムへの関心の高まり、医療ツーリズムの普及拡大、などによって大幅な成長が見込まれます。新興国における修復技術の受容性を高めることが、セルライト治療市場の発展を後押しすると思われます。但し、治療後の腫れやむくみ、および熟練した経験豊富な皮膚科医/形成外科医のの不足に関する懸念が市場の発展を妨げる可能性があります。
目次
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 MARKET STRUCTURE
2.4 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING NUMBER OF OBESE CASES ACROSS THE GLOBE
4.2.2 RISING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES
4.2.3 GROWING MEDICAL TOURISM INDUSTRY
4.3 RESTRAINTS
4.3.1 CONCERNS PERTAINING TO BRUISING AND SWELLING
4.3.2 SHORTAGE OF TRAINED AND EXPERIENCED DERMATOLOGIST/ PLASTIC SURGEON
4.4 OPPORTUNITY
4.4.1 GROWING ADOPTION OF COSMETIC PROCEDURES IN EMERGING ECONOMIES
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION AND SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF BUYERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL CELLULITE TREATMENT MARKET
5.3.1 IMPACT ON SUPPLY CHAIN
5.3.2 IMPACT ON PATIENTS SUFFERING FROM CELLULITE
5.3.3 IMPACT ON DEMAND AND SUPPLY
5.3.4 IMPACT ON REGIONS
6 GLOBAL CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE
6.1 OVERVIEW
6.2 NON-INVASIVE
6.3 TOPICAL
6.4 MINIMALLY INVASIVE
6.5 OTHERS
7 GLOBAL CELLULITE TREATMENT MARKET, BY CELLULITE TYPE
7.1 OVERVIEW
7.2 SOFT CELLULITE
7.3 HARD CELLULITE
7.4 EDEMATOUS CELLULITE
8 GLOBAL CELLULITE TREATMENT MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS
8.3 SPECIALISED DERMATOLOGY CLINICS
8.4 AMBULATORY SURGICAL CENTERS
8.5 OTHERS
9 GLOBAL CELLULITE TREATMENT MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 UK
9.3.3 FRANCE
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 SOUTH KOREA
9.4.5 AUSTRALIA
9.4.6 REST OF ASIA PACIFIC
9.5 REST OF THE WORLD
9.5.1 MIDDLE EAST
9.5.2 AFRICA
9.5.3 LATIN AMERICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL CELLULITE TREATMENT MARKET
10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL CELLULITE TREATMENT MARKET
10.5 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.5.1 PRODUCT LAUNCH/PRODUCT APPROVAL
11 COMPANY PROFILES
11.1 HOLOGIC, INC.
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS/SERVICES OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 NUBWAY CO.LTD.
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS/SERVICES OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.2.6 KEY STRATEGIES
11.3 MERZ PHARMA GMBH & CO. KGAA
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS/SERVICES OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.3.6 KEY STRATEGIES
11.4 ZIMMER AESTHETICS
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS/SERVICES OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 SWOT ANALYSIS
11.4.6 KEY STRATEGIES
11.5 CYMEDICS
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS/SERVICES OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 SWOT ANALYSIS
11.5.6 KEY STRATEGIES
11.6 CYNOSURE, LLC
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS/SERVICES OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 KEY STRATEGIES
11.7 INCELER MEDIKAL CO. LTD.
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCTS/SERVICES OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 KEY STRATEGIES
11.8 CANDELA MEDICAL
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS/SERVICES OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 KEY STRATEGIES
11.9 CUTERA, INC.
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCTS/SERVICES OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 KEY STRATEGIES
11.10 BEIJING SINCOHEREN S & T DEVELOPMENT CO., LTD.
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCTS/SERVICES OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 KEY STRATEGIES
12 APPENDIX
12.1 REFERENCES
12.2 RELATED REPORTS
